These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31269588)

  • 1. [β-catenin nuclear translocation represses thyroid cancer stem cells differentiating into cells with sodium-iodine symporter functional expression].
    Lan L; Deng W; Cui D; Chen HL; Huo LL; Zuo QY; Li W; Zhang GY; Luo Y
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1904-1910. PubMed ID: 31269588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nuclear translocation of β-catenin represses membrane localization of NIS in human thyroid cancer cells].
    Lan L; Deng W; Chen H; Huo L; Deng L; Zhang G; Luo Y
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(11):891-6. PubMed ID: 27045654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
    Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting β-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization.
    Lan L; Basourakos S; Cui D; Zuo X; Deng W; Huo L; Chen L; Zhang G; Deng L; Shi B; Luo Y
    Oncol Rep; 2017 Jan; 37(1):426-434. PubMed ID: 27840971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
    Chai W; Ye F; Zeng L; Li Y; Yang L
    J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelial-mesenchymal transition induces cancer stem cell generation in human thyroid cancer cells in vitro].
    Lan L; Luo Y; Cui D; Shi BY; Deng W; Huo LL; Chen HL; Zhang GY; Deng LL
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1261-5. PubMed ID: 23902621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.
    Gaertner FC; Rohde F; Mueller J; Blechert B; Janssen KP; Essler M
    Int J Cancer; 2009 Dec; 125(12):2783-91. PubMed ID: 19569179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATRA increases iodine uptake and inhibits the proliferation and invasiveness of human anaplastic thyroid carcinoma SW1736 cells: Involvement of β-catenin phosphorylation inhibition.
    Lan L; Basourakos S; Cui D; Zuo X; Deng W; Huo L; Chen H; Zhang G; Deng L; Shi B; Luo Y
    Oncol Lett; 2017 Dec; 14(6):7733-7738. PubMed ID: 29344218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
    Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 17. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
    Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
    J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
    Chung T; Youn H; Yeom CJ; Kang KW; Chung JK
    PLoS One; 2015; 10(11):e0142984. PubMed ID: 26599396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.